OncoCyte Corporation (OCX)
NASDAQ: OCX · IEX Real-Time Price · USD
3.210
+0.090 (2.88%)
At close: Jul 19, 2024, 4:00 PM
3.130
-0.080 (-2.49%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
OncoCyte Market Cap
OncoCyte has a market cap or net worth of $42.90 million as of July 22, 2024. Its market cap has increased by 21.19% in one year.
Market Cap
42.90M
Enterprise Value
38.96M
1-Year Change
21.19%
Ranking
Category
Stock Price
$3.21
Market Cap Chart
Since January 4, 2016, OncoCyte's market cap has decreased from $228.70M to $42.90M, a decrease of -81.24%. That is a compound annual growth rate of -17.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 42.90M | 107.25% |
Dec 29, 2023 | 20.70M | -45.67% |
Dec 30, 2022 | 38.10M | -80.96% |
Dec 31, 2021 | 200.10M | 24.52% |
Dec 31, 2020 | 160.70M | 37.47% |
Dec 31, 2019 | 116.90M | 108.38% |
Dec 31, 2018 | 56.10M | -61.60% |
Dec 29, 2017 | 146.10M | -27.82% |
Dec 30, 2016 | 202.40M | -11.50% |
Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BioXcel Therapeutics | 43.91M |
Envoy Medical | 43.90M |
Fortress Biotech | 43.89M |
Lexaria Bioscience | 43.16M |
NeueHealth | 43.10M |
Tempest Therapeutics | 42.88M |
Bright Green | 42.64M |
Movano | 41.13M |